Beneficial glycaemic effects of high-amylose barley bread compared to wheat bread in type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Beneficial glycaemic effects of high-amylose barley bread compared to wheat bread in type 2 diabetes. / Bohl, Mette; Gregersen, Søren; Zhong, Yuyue; Hebelstrup, Kim Henrik; Hermansen, Kjeld.

In: European Journal of Clinical Nutrition, Vol. 78, 2024, p. 243-250.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Bohl, M, Gregersen, S, Zhong, Y, Hebelstrup, KH & Hermansen, K 2024, 'Beneficial glycaemic effects of high-amylose barley bread compared to wheat bread in type 2 diabetes', European Journal of Clinical Nutrition, vol. 78, pp. 243-250. https://doi.org/10.1038/s41430-023-01364-x

APA

Bohl, M., Gregersen, S., Zhong, Y., Hebelstrup, K. H., & Hermansen, K. (2024). Beneficial glycaemic effects of high-amylose barley bread compared to wheat bread in type 2 diabetes. European Journal of Clinical Nutrition, 78, 243-250. https://doi.org/10.1038/s41430-023-01364-x

Vancouver

Bohl M, Gregersen S, Zhong Y, Hebelstrup KH, Hermansen K. Beneficial glycaemic effects of high-amylose barley bread compared to wheat bread in type 2 diabetes. European Journal of Clinical Nutrition. 2024;78:243-250. https://doi.org/10.1038/s41430-023-01364-x

Author

Bohl, Mette ; Gregersen, Søren ; Zhong, Yuyue ; Hebelstrup, Kim Henrik ; Hermansen, Kjeld. / Beneficial glycaemic effects of high-amylose barley bread compared to wheat bread in type 2 diabetes. In: European Journal of Clinical Nutrition. 2024 ; Vol. 78. pp. 243-250.

Bibtex

@article{f1f72021a6754d6db94f91c561fea0a4,
title = "Beneficial glycaemic effects of high-amylose barley bread compared to wheat bread in type 2 diabetes",
abstract = "Background: Cereals foods with a high content of dietary fibres or amylose have potential to lower postprandial glucose levels. Optimisation of cereal foods may improve management of type 2 diabetes (T2D). Methods: We investigated the impact on 4 h postprandial glucose responses given as incremental area under curve (iAUC) of bread made of either 50% RNAi-based (genetically modified) amylose-only barley flour (AmOn) (and 50% wheat flour), 50% hulless barley flour (and 50% wheat flour) or 75% hulless barley (and 25% wheat flour) in subjects with T2D compared with 100% wheat flour bread. Design: Twenty adults with T2D were randomly allocated to one of four breads at four separate visits. We measured fasting and 4 h postprandial responses of glucose, insulin, glucagon, triacylglycerol (TG), free fatty acids (FFA), glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP). Mixed model ANOVA was used to examine the differences. Results: Bread made from 50% AmOn lowered the 4 h postprandial glucose by 34%, 27%, 23% (P < 0.05) compared with 100% wheat, 50% or 75% hulless barley, respectively. Bread made from 75% hulless barley reduced the postprandial glucose response (iAUC) by 11% (P < 0.05) compared to 100% wheat bread. Postprandial insulin responses (iAUC) were reduced for 50% AmOn compared with 100% wheat and 50% hulless barley and for 75% hulless compared to 50% hulless barley bread (P < 0.05). 4 h postprandial glucagon (tAUC) did not differ between the four bread types (P > 0.05). Lower postprandial GIP (iAUC) was observed after all barley breads compared to 100% wheat (P < 0.05), whereas no difference was seen in postprandial GLP-1. Postprandial TG and FFA (tAUC) were difficult to judge due to differences in fasting values. Conclusions: Bread made by replacing wheat flour with either 50% high-amylose or 75% hulless barley flour lowered postprandial glucose responses compared to 100% wheat bread indicating a beneficial impact on glucose regulation in T2D subjects. This trial was registered at clinicaltrials.gov as NCT04646746.",
author = "Mette Bohl and S{\o}ren Gregersen and Yuyue Zhong and Hebelstrup, {Kim Henrik} and Kjeld Hermansen",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2024",
doi = "10.1038/s41430-023-01364-x",
language = "English",
volume = "78",
pages = "243--250",
journal = "European Journal of Clinical Nutrition",
issn = "0954-3007",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - Beneficial glycaemic effects of high-amylose barley bread compared to wheat bread in type 2 diabetes

AU - Bohl, Mette

AU - Gregersen, Søren

AU - Zhong, Yuyue

AU - Hebelstrup, Kim Henrik

AU - Hermansen, Kjeld

N1 - Publisher Copyright: © 2023, The Author(s).

PY - 2024

Y1 - 2024

N2 - Background: Cereals foods with a high content of dietary fibres or amylose have potential to lower postprandial glucose levels. Optimisation of cereal foods may improve management of type 2 diabetes (T2D). Methods: We investigated the impact on 4 h postprandial glucose responses given as incremental area under curve (iAUC) of bread made of either 50% RNAi-based (genetically modified) amylose-only barley flour (AmOn) (and 50% wheat flour), 50% hulless barley flour (and 50% wheat flour) or 75% hulless barley (and 25% wheat flour) in subjects with T2D compared with 100% wheat flour bread. Design: Twenty adults with T2D were randomly allocated to one of four breads at four separate visits. We measured fasting and 4 h postprandial responses of glucose, insulin, glucagon, triacylglycerol (TG), free fatty acids (FFA), glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP). Mixed model ANOVA was used to examine the differences. Results: Bread made from 50% AmOn lowered the 4 h postprandial glucose by 34%, 27%, 23% (P < 0.05) compared with 100% wheat, 50% or 75% hulless barley, respectively. Bread made from 75% hulless barley reduced the postprandial glucose response (iAUC) by 11% (P < 0.05) compared to 100% wheat bread. Postprandial insulin responses (iAUC) were reduced for 50% AmOn compared with 100% wheat and 50% hulless barley and for 75% hulless compared to 50% hulless barley bread (P < 0.05). 4 h postprandial glucagon (tAUC) did not differ between the four bread types (P > 0.05). Lower postprandial GIP (iAUC) was observed after all barley breads compared to 100% wheat (P < 0.05), whereas no difference was seen in postprandial GLP-1. Postprandial TG and FFA (tAUC) were difficult to judge due to differences in fasting values. Conclusions: Bread made by replacing wheat flour with either 50% high-amylose or 75% hulless barley flour lowered postprandial glucose responses compared to 100% wheat bread indicating a beneficial impact on glucose regulation in T2D subjects. This trial was registered at clinicaltrials.gov as NCT04646746.

AB - Background: Cereals foods with a high content of dietary fibres or amylose have potential to lower postprandial glucose levels. Optimisation of cereal foods may improve management of type 2 diabetes (T2D). Methods: We investigated the impact on 4 h postprandial glucose responses given as incremental area under curve (iAUC) of bread made of either 50% RNAi-based (genetically modified) amylose-only barley flour (AmOn) (and 50% wheat flour), 50% hulless barley flour (and 50% wheat flour) or 75% hulless barley (and 25% wheat flour) in subjects with T2D compared with 100% wheat flour bread. Design: Twenty adults with T2D were randomly allocated to one of four breads at four separate visits. We measured fasting and 4 h postprandial responses of glucose, insulin, glucagon, triacylglycerol (TG), free fatty acids (FFA), glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP). Mixed model ANOVA was used to examine the differences. Results: Bread made from 50% AmOn lowered the 4 h postprandial glucose by 34%, 27%, 23% (P < 0.05) compared with 100% wheat, 50% or 75% hulless barley, respectively. Bread made from 75% hulless barley reduced the postprandial glucose response (iAUC) by 11% (P < 0.05) compared to 100% wheat bread. Postprandial insulin responses (iAUC) were reduced for 50% AmOn compared with 100% wheat and 50% hulless barley and for 75% hulless compared to 50% hulless barley bread (P < 0.05). 4 h postprandial glucagon (tAUC) did not differ between the four bread types (P > 0.05). Lower postprandial GIP (iAUC) was observed after all barley breads compared to 100% wheat (P < 0.05), whereas no difference was seen in postprandial GLP-1. Postprandial TG and FFA (tAUC) were difficult to judge due to differences in fasting values. Conclusions: Bread made by replacing wheat flour with either 50% high-amylose or 75% hulless barley flour lowered postprandial glucose responses compared to 100% wheat bread indicating a beneficial impact on glucose regulation in T2D subjects. This trial was registered at clinicaltrials.gov as NCT04646746.

U2 - 10.1038/s41430-023-01364-x

DO - 10.1038/s41430-023-01364-x

M3 - Journal article

C2 - 37940671

AN - SCOPUS:85176118689

VL - 78

SP - 243

EP - 250

JO - European Journal of Clinical Nutrition

JF - European Journal of Clinical Nutrition

SN - 0954-3007

ER -

ID: 382550559